Tuesday, August 25, 2020

Resistance Essays - Inorganic Solvents, Drug Paraphernalia

Opposition Security - should consistently wear wellbeing glasses and we ought to be mindful so as not to drop any corrosive. Reasonable test-we should ensure that we utilize a similar size, sum furthermore, generally a similar mass of chips, this is on the grounds that we need to keep the chips generally a similar completely through the test with the goal that it will be a reasonable test and the outcomes we be according to one another, in any case the outcomes will be totally unique to what we will expect and it will destroy the examination. We should likewise take our readings at similar stretches all through the examination for example I will take a perusing like clockwork for the entirety of my examinations. I foresee that the more focused the corrosive the snappier the response will take place, in light of the fact that the more focused the corrosive is then it will make the chips respond quicker and more hydrogen will be emitted in a snappier time. The littler the stones are, the considerably snappier the response will occur, this is on the grounds that the corrosive has a littler surface region to follow up on. Gear We will require a bubbling tube, calcium carbonate chips, hydrochloric corrosive, water, a stop watch, a gas syringe and a bung on the highest point of the bubbling cylinder with a conveyance tube associated to the gas syringe. I will likewise require a stand and a brace to clutch the syringe. Technique When doing my examinations I will utilize a similar methodology all through. When I have set up the device I will apportion 5cm3 of corrosive in an estimating cylinder and afterward empty it into a bubbling cylinder. At that point I will be prepared with the stop watch and afterward rapidly drop in the chips into the corrosive, push on the bung and start the stop watch. This should all be done in a short space of time. From that point, I should take the perusing from the volume in the gas syringe at regular intervals precisely until it perusing isn't changing very much. I should record the outcomes in a table and afterward review it flawless later. The factors which may influence how well the test functions are the manner by which rapidly the chips are placed in and afterward the bungplaced on and the stop watch squeezed. In spite of the fact that this is a factor it isn't generally a main consideration that will influence the final products, also, as long as the time everything takes is kept consistent all through then it ought to not make any difference to an extreme. Different variables are what sort of water to use for weakening, I could either utilize water from the tap which isn't unadulterated or it might be excessively hot or then again excessively cold, or I could utilize refined water. Faucet water may have a few things in it which may influence the outcomes. The temperature likewise could influence the explore in such a case that warmth is applied then the particles would move around additional what's more, influence the outcomes , and afterward more gas would be made. I figure I will require one outcome for every focus and later in the event that I have to rehash any investigations I can do. To get the best outcomes I have to utilize the hardware in the best conceivable way. A few different ways of doing this is contort the gas syringe back and forward in order to not stall out, which could influence our outcomes. Something else is sifter the chips so to get the best marbles we can. An significant point is that I should get the perfect measure of corrosive and the best size what's more, measure of marbles, provided that for 4mol on the off chance that I utilized around 4 chips, at that point excessively gas will be delivered and the syringe will go over the 100 mm3 region in the syringe in a snappy time, thus we won't have the option to take right readings. So to over come this difficult we will test to perceive what number of chips and at what size will be the best to utilize. This is the place my trialexperiments, that I did before I began, proved to be useful on the grounds that it permitted me to comprehend what sum and size of chips to utilize. Subsequent to doing my preliminary tests I worked out that 1 medium estimated chip around 0.63g would be ideal to utilize. However, I should recollect that if I utilize 1 chip then I should utilize 1 chip generally a similar size

Saturday, August 22, 2020

Beowulf Comparison Essay Example | Topics and Well Written Essays - 750 words

Beowulf Comparison - Essay Example Portrayal involved the poet’s creative mind and the topics around those occasions with most sonnets having heroes and opponents. This is the reason the sonnets had parts of legends, fights, dauntlessness, dependability, quarrels, contemplations on destiny and life including brutal angles, for example, banish, beasts, just as temporariness and fortune. ‘Beowulf’ is the same as Old English sonnets, one of them being ‘Battle of Maldon’. The two sonnets are written in Old English, which utilizes an alternate sort of punctuation from the cutting edge one. ‘Battle of Maldon’ is an early English sonnet written in Anglo-Saxon style (Bowman 91-115). The early English developed to what is spoken in the current occasions and would in general be Germanic while showing negligible French and Latin impact. So as to comprehend the sonnet from a more profound perspective, understudies ought to be by one way or another acquainted with Anglo-Saxon verse basics. Old English Saxon writers utilized alliterative section. This type of refrain utilizes similar sounding word usage as the major expressive gadget to join lines of verse. This is something contrary to gadgets utilized in organizing rhymes. In similar sounding word usage, the a-section or first 50% of a line is connected with the b-stanza or second half th rough comparative beginning sounds. Furthermore, a caesura partitions the two parts. This is a respite typically spoke to as a hole showing up on a page. The sonnets have decreased components of interior rhyme yet have rehashed phrases, which they reused. Both ‘Battle of Maldon’ and ‘Beowulf’ are a progression of refrains, which describe of chivalrous, legendary occasions from a Germanic past and end with the poet’s predicament. The Anglo-Saxon style delineates a structure known as accentual refrain with four beats in each line meaning each half line has two beats. Similar sounding word usage is satisfied in the sonnet through utilization of appellations, which is a recipe of elocution unique in relation to the cutting edge English. Another noteworthy elaborate gadget in Beowulf is the

Sunday, August 2, 2020

Cellworks Group

Cellworks Group INTRODUCTIONMartin: This time we are in  San Jose,  in Cellworks Group office with Taher. Taher, who are you and what do you do?Taher: My background, my academic background is engineering and business school. Before starting this company Cellworks, I was almost 15 years in the semiconductor business in the automation engineering business. The idea behind Cellworks was to take those concepts and best practices and apply them into a completely different domain and make impact that industry.Martin: I totally understand that you have automation and modeling background, why did you choose health care?Taher: What happened is, in the semiconductor space for example, we have reached a point where every Christmas we would come up with a new product. We knew in 6 weeks development cycle. And every time we sent a design for fabrication to  Taiwan,  almost 99% certain that youll get working silicon.When we saw life sciences, everything was different. It took more than 10-12 years to get a produc t out. Less than 8% chance of success and the development cost was almost 10 times larger than in the semiconductor business.So from all the business vectors and so forth, it seemed like a very opportune industry in order to apply what we have successfully deployed in the chip business to the life sciences.Martin: So your basic hypothesis was, we, with our technology can minimize or lower the deployment cost in the health care industry?Taher: Yes, if I could increase the success rate, because the biggest challenge was the failures. So either you improve your success rate or if you have a bad product or bad architecture, you fail early. So our whole philosophy was that effectually through simulation and modeling, you can actually improve your probability of success in an industry where the success rate was extremely low.Martin: Great!BUSINESS MODELMartin: Taher, lets talk briefly about the business model. How does it currently work?Taher: Well, the core competency in the organization is the technology, which is the simulation technology. So every aspect of it is governed based on that. So we had few multiple choices in terms of business models.One was effectually being a service provider, and we early on decided that service is not something which we wanted to be in, as a services company.The second option was being a technology provider, being an enabler to the pharmaceutical industry. We decided to follow a business model where we would be our own consumers of the technology after we intensively validated and designed products using the technology which we can monetized by engaging with different players in the ecosystem.Martin: And now your first product is based on oncology. Can you tell us a little bit more about this, how this works and how is it applied in the typical work process of your client?Taher: Right, so cancer is one of our main focus areas. One of the main driving factors for selecting cancer is because of the whole moment of personalization of treatments. It so happens that in cancers, every patients genomic signature is completely different. And in that context, one size fits all approach does not work.So what traditionally used to be a block buster business model, where you take a drug product and deploy it to a large consumer base, that model falls apart based on personalization of medicine. And almost you start having a long tail business model.So in the context of cancer, the patients genomic signature is what we use to create a simulation of the cancer patient. And effectively then designed a treatment, which is personalized to that particular patient, and effectively either test it using the patients cancer cells outside the patient in the lab, or find a mechanism by which to take it to clinical transition pathway.Martin: Okay. I totally understand that once you have the date set, then you can make the predictions on what kind of treatment to use. But in the first place, how do you get this data set that you can r eally use to make a sensible prediction?Taher: So the core technology is simulation technology. Its effectively built based on, so all the last many decades there have been, in the science field, there has been tons and tons of publications, which effectively talk about this specific connection of the different biological players.So, the simulation technology is analogous to maps. You can think of it as Google Maps with the difference. So, it actually builds in a connection by connection that guides the pathways inside a cancer cell. With the added difference that you can actually simulate it, you can actually perturb any pathway, any  nerves  or any combinations of them, and see the effect of it propagating down the network.So essentially its been built based on information published out there, and aggregated together manually in a simulation model. So you can actually do what if analysis and run studies and experiments, to predict what would be the effect of this perturbation, eit her drug perturbations or other perturbations on the cancer end points.Martin: Is this the only data that is flowing in or did you also develop a machine learning algorithm that learns over time?Taher: We have induced machine learning. Effectually what happens in science that there are a lot of contradictory data sets. To avoid basically the phenomena of garbage in and garbage out, weve effectively used manual mechanism to aggregate the data and all kinds of automation is applied thereafter.So when youre building the model, we manually look at each and every research paper, the experiment conditions and all the parameters which determine the verification of the data, and then thereafter all the steps are automated.ONCOLOGY ECOSYSTEM GO-TO-MARKET STRATEGYMartin: Can you tell us a little bit more about the oncology ecosystem and what is your go-to market strategy?Taher: Well, we have 2 ways of approaching it.One is in the process of modeling different patients and different segments of patient population. We are coming up with our own  predict programs, which we are patenting and validating. So we are in-house building a library of patterns of  predict  programs, targeting a very specific patient segments. So that’s for medium to long term strategy, in terms of collecting a library of patterns.More for a short term to medium term go-to market strategy is, were looking at how this personalization can be deployed as a decision making algorithm in the clinical practice. So in that capacity, weve started talking to clinical groups who effectively are collecting patients tissue samples and getting it genomically profiled. And working with them, and collaborating with them, how we can actually build the next layer of personalization, where they can actually translate that information into actionable insight.Martin: Okay. Taher, can you tell us a little bit about the players in this oncology market?Taher: In general, in pharmaceutical business and also of course in oncology business, there are multiple players in the ecosystem. This is probably one of the industries where typically examples of multi-sided business model. This is truly a multi-sided.In this business, the clinicians are the final arbitrators in terms of making decision, in terms of what treatment interventions. The consumer or the patient effectively take the direction from the physicians and does not pay for the services. So the group which pays for it is the insurance companies and the payers. And the suppliers into the ecosystem are the pharmaceutical companies, the diagnostic, genomics companies.The whole industry is then regulated by FDA for example, and other regulatory body. So you have a multi-factorial ecosystem.In terms of the strategy for launching this go to market strategy, we have to start working with the clinical groups in terms of building validation, credibility and getting them on board. Once that process is ongoing, then you effectually go to patient advocacy groups as well as working with different members, like the pharmaceutical and diagnostics. You indirectly or directly influence the payers to start paying for this technology and solutions.Martin: Okay. Great!MARKET DEVELOPMENTMartin: Lets talk briefly about the market development, especially in oncology, for example. I mean this is quite a big industry in the health care industry. Can you tell us a little bit more about the technology drivers over there and maybe some trends you have identified over the last years?Taher: I think the personalization of cancer treatment has become mainstream. This is something which is widely accepted and deployed in all major, major clinical centers globally, have the initiative, in terms of being able to find the right treatment for the right patient. I think that is the main focus.The idea behind the simulation is the fact, there are tons and tons of big data which is being generated as a consequence of the next sequencing for example, which comp anies are deploying. So the cost of sequencing, which used to be in thousands and hundred of thousands, has dropped down to less than a thousand dollars now.The ability to sequence this cancer tissues, be able to generate this big amount of data in gigabytes, is effectively creating a situation where you have the data but you dont have an actionable pathway to intervene or influence the technical decisions. Thats where the predictive technology fits in beautifully, in terms of being able to take advantage of the move to big data, creating a patient specific of  thought,  and then through the modeling approach coming up with a scientific rational and a treatment, which is actionable and something which a clinical group can actually utilize for intervention.Martin: Great!ADVICE TO ENTREPRENEURS In San Jose (CA), we meet the founder and CEO of Cellworks Group, Taher Abbasi. Taher shares his story how he came up with the idea and founded his company, how the oncology market is currently working, as well as he provides some advice for young entrepreneurs.The transcript of the interview is provided below.INTRODUCTIONMartin: This time we are in  San Jose,  in Cellworks Group office with Taher. Taher, who are you and what do you do?Taher: My background, my academic background is engineering and business school. Before starting this company Cellworks, I was almost 15 years in the semiconductor business in the automation engineering business. The idea behind Cellworks was to take those concepts and best practices and apply them into a completely different domain and make impact that industry.Martin: I totally understand that you have automation and modeling background, why did you choose health care?Taher: What happened is, in the semiconductor space for example, we have reached a point where every Christmas we would come up with a new product. We knew in 6 weeks development cycle. And every time we sent a design for fabrication to  Taiwan,  almost 99% certain that youll get working silicon.When we saw life sciences, everything was different. It took more than 10-12 years to get a product out. Less than 8% chance of success and the development cost was almost 10 times larger than in the semiconductor business.So from all the business vectors and so forth, it seemed like a very opportune industry in order to apply what we have successfully deployed in the chip business to the life sciences.Martin: So your basic hypothesis was, we, with our technology can minimize or lower the deployment cost in the health care industry?Taher: Yes, if I could increase the success rate, because the biggest challenge was the failures. So either you improve your success rate or if you have a bad product or bad architecture, you fail early. So our whole philosophy was that effectua lly through simulation and modeling, you can actually improve your probability of success in an industry where the success rate was extremely low.Martin: Great!BUSINESS MODELMartin: Taher, lets talk briefly about the business model. How does it currently work?Taher: Well, the core competency in the organization is the technology, which is the simulation technology. So every aspect of it is governed based on that. So we had few multiple choices in terms of business models.One was effectually being a service provider, and we early on decided that service is not something which we wanted to be in, as a services company.The second option was being a technology provider, being an enabler to the pharmaceutical industry. We decided to follow a business model where we would be our own consumers of the technology after we intensively validated and designed products using the technology which we can monetized by engaging with different players in the ecosystem.Martin: And now your first produ ct is based on oncology. Can you tell us a little bit more about this, how this works and how is it applied in the typical work process of your client?Taher: Right, so cancer is one of our main focus areas. One of the main driving factors for selecting cancer is because of the whole moment of personalization of treatments. It so happens that in cancers, every patients genomic signature is completely different. And in that context, one size fits all approach does not work.So what traditionally used to be a block buster business model, where you take a drug product and deploy it to a large consumer base, that model falls apart based on personalization of medicine. And almost you start having a long tail business model.So in the context of cancer, the patients genomic signature is what we use to create a simulation of the cancer patient. And effectively then designed a treatment, which is personalized to that particular patient, and effectively either test it using the patients cancer cells outside the patient in the lab, or find a mechanism by which to take it to clinical transition pathway.Martin: Okay. I totally understand that once you have the date set, then you can make the predictions on what kind of treatment to use. But in the first place, how do you get this data set that you can really use to make a sensible prediction?Taher: So the core technology is simulation technology. Its effectively built based on, so all the last many decades there have been, in the science field, there has been tons and tons of publications, which effectively talk about this specific connection of the different biological players.So, the simulation technology is analogous to maps. You can think of it as Google Maps with the difference. So, it actually builds in a connection by connection that guides the pathways inside a cancer cell. With the added difference that you can actually simulate it, you can actually perturb any pathway, any  nerves  or any combinations of them, and see the effect of it propagating down the network.So essentially its been built based on information published out there, and aggregated together manually in a simulation model. So you can actually do what if analysis and run studies and experiments, to predict what would be the effect of this perturbation, either drug perturbations or other perturbations on the cancer end points.Martin: Is this the only data that is flowing in or did you also develop a machine learning algorithm that learns over time?Taher: We have induced machine learning. Effectually what happens in science that there are a lot of contradictory data sets. To avoid basically the phenomena of garbage in and garbage out, weve effectively used manual mechanism to aggregate the data and all kinds of automation is applied thereafter.So when youre building the model, we manually look at each and every research paper, the experiment conditions and all the parameters which determine the verification of the data, and then thereafter all the steps are automated.ONCOLOGY ECOSYSTEM GO-TO-MARKET STRATEGYMartin: Can you tell us a little bit more about the oncology ecosystem and what is your go-to market strategy?Taher: Well, we have 2 ways of approaching it.One is in the process of modeling different patients and different segments of patient population. We are coming up with our own  predict programs, which we are patenting and validating. So we are in-house building a library of patterns of  predict  programs, targeting a very specific patient segments. So that’s for medium to long term strategy, in terms of collecting a library of patterns.More for a short term to medium term go-to market strategy is, were looking at how this personalization can be deployed as a decision making algorithm in the clinical practice. So in that capacity, weve started talking to clinical groups who effectively are collecting patients tissue samples and getting it genomically profiled. And working with them, and collabora ting with them, how we can actually build the next layer of personalization, where they can actually translate that information into actionable insight.Martin: Okay. Taher, can you tell us a little bit about the players in this oncology market?Taher: In general, in pharmaceutical business and also of course in oncology business, there are multiple players in the ecosystem. This is probably one of the industries where typically examples of multi-sided business model. This is truly a multi-sided.In this business, the clinicians are the final arbitrators in terms of making decision, in terms of what treatment interventions. The consumer or the patient effectively take the direction from the physicians and does not pay for the services. So the group which pays for it is the insurance companies and the payers. And the suppliers into the ecosystem are the pharmaceutical companies, the diagnostic, genomics companies.The whole industry is then regulated by FDA for example, and other regulat ory body. So you have a multi-factorial ecosystem.In terms of the strategy for launching this go to market strategy, we have to start working with the clinical groups in terms of building validation, credibility and getting them on board. Once that process is ongoing, then you effectually go to patient advocacy groups as well as working with different members, like the pharmaceutical and diagnostics. You indirectly or directly influence the payers to start paying for this technology and solutions.Martin: Okay. Great!MARKET DEVELOPMENTMartin: Lets talk briefly about the market development, especially in oncology, for example. I mean this is quite a big industry in the health care industry. Can you tell us a little bit more about the technology drivers over there and maybe some trends you have identified over the last years?Taher: I think the personalization of cancer treatment has become mainstream. This is something which is widely accepted and deployed in all major, major clinical centers globally, have the initiative, in terms of being able to find the right treatment for the right patient. I think that is the main focus.The idea behind the simulation is the fact, there are tons and tons of big data which is being generated as a consequence of the next sequencing for example, which companies are deploying. So the cost of sequencing, which used to be in thousands and hundred of thousands, has dropped down to less than a thousand dollars now.The ability to sequence this cancer tissues, be able to generate this big amount of data in gigabytes, is effectively creating a situation where you have the data but you dont have an actionable pathway to intervene or influence the technical decisions. Thats where the predictive technology fits in beautifully, in terms of being able to take advantage of the move to big data, creating a patient specific of  thought,  and then through the modeling approach coming up with a scientific rational and a treatment, which is actio nable and something which a clinical group can actually utilize for intervention.Martin: Great!ADVICE TO ENTREPRENEURSMartin: Taher, we always try to help our first time entrepreneurs learn from great entrepreneurs like you. What advice can you give them, especially related when somebody comes to you and says, I would like to start a health care company. What would be your advice?Taher: I think the biggest thing to watch in a health care business is effectively, if youre going to be regulated, so for example the regulatory aspects are key considerations in the health care business. So if youre doing something which is beyond that, for example if youre coming with a health care application on mobile phones. So those things would be less regulated and the ability for you to go to market is going to be easier and faster.If the interest is to be able to get to market in a couple of years, you need to watch on the regulatory side of things, what are the implications are.Beyond that I thi nk which is true for health care or any business right now, pretty much you dont have all the answers when you started a venture. Looking for all the answers on day 1, I never have seen that happened in my personal lifetime. In terms of knowing all the answers. In that sense, you have to take the leap of faith out there.The third and final point which is very critical for most ventures to start is the financing aspect. If you are, if the business require some kind of external financing down the road, if theres a strategy to build a prototype through some kind of a bootstrap method or some other technique, that would be ideal because the prototype with the idea is a good inflection point for the external financing.Martin: Great! In terms of health care, isnt it quite expensive to bootstrap? Lets say if I would like to try to develop a cancer treatment?Taher: Absolutely. I think not only its expensive and difficult to develop the treatment, also the aspect of taking it through the cli nical study is prohibitively expensive. So, I  guess if were looking at large sciences, you may have to look at those peripheral areas. If intervention is 1 aspect of a treatment, 1 aspect of it, it could be in areas for example, electronic health records, different kinds of bioinformatics solutions and other kinds of technology solutions which sort of sit on the periphery.I guess, the closer you move towards intervening and impacting the treatment, the higher the bar, in terms of regulatory as well as the development process.Martin: Taher, what would you advice somebody who is currently working as an employee and just thinking about should I start a startup or not. What would you advice him?Taher: It seems like, given the recent and all trends and the excitement towards new ventures, it’s a good time, at least right now, for the last couple of years it has been a very good time for starting. If you have the right idea.The main thing, in many of these starting a new venture, you c ant expect to get all the ideas. In fact almost always, the business model of the plan which started out with and the plan which you actually end up executing, turns out to be quite different. So given that aspect, when the right idea is there and the ability for you to sort of, and you think that you have the right team to execute on it, its a good time to start a new venture.Martin: Okay. Great! Taher, thank you very much for your time. Cellworks Group is a very good example of how technology can help all of us become healthy and maybe have less cancer. So next time you think about starting your own company, think about how technology can influence your industry.

Friday, May 22, 2020

Surviving Children Who Now Have Posttraumatic Syndrome...

surviving children who now have posttraumatic syndrome disorder (Johnathan, 2011). The last part of Kenneth Burke’s pentad is the purpose. The purpose of the film was to bring awareness to the U.S. involvement in Cambodia. Prior to the release of the movie, we knew little about how U.S. policies spilled over into Cambodia. The film made a human connection with the genocide of many Cambodians. The purpose was to shed light on the villains who were Pol Pot and the Khmer Rouge (Magid 112). Another purpose was to bring the atrocities to the light. Another purpose of the film was to highlight the ravages of war, genocides, and mass murders. The purpose of the movie was to bring an emotional connection on a human level. The movies based on a true story that wanted to depict the realism of war, and the ravages of war. The audience knows the movies based on a true story so rather than trying to make it a dramatic war film; it wanted the viewers to connect with the relationship struggle of Dith Pran and the helpless Cambodians left to fend for themselves (Cook 223). Looking through the lens, the movie was able to persuade the audience to feel the tragic deaths and scenes of civil war. Conclusion After assessing the four types of genocides and the â€Å"Killing Fields,† I was able to conclude the overall effectiveness of the movie was very high. The film was able to connect with a new audience that has never heard about the Cambodian genocide by using pathos throughout the movie. TheShow MoreRelatedThe Case : Michelle Knight1587 Words   |  7 PagesThe case: Michelle Knight Michelle knight is a 34 year old Caucasian women who was born April 1981, later on moving to Cleveland Ohio where she was raised (Knight, 2015). Growing up she recalls not having a good relationship with her mother, she remembers â€Å"a chaotic childhood marked by neglect and abuse† (Connors, 2014). In school she was bullied and eventually sexually assaulted â€Å"By a group of males â€Å"resulting in her dropping out of school and later finding out her had become pregnant as a resultRead MorePhysical Effects Of Child Sexual Abuse2049 Words   |  9 PagesUniversity When we are children, the smallest things can have such immense impacts on one’s life. A child’s world generally revolves around complete possibility, positivity, and spontaneity. However, this natural process can all be easily violated when a child is subjected to sexual abuse. This violation comes with an abundance of psychological, social, and psychological effects. Mainly looking at the physical effects, such immoral retribution subjugates children too, it can ultimately saidRead MoreDescription Of An Example Of A Presentation8050 Words   |  33 PagesAttention Deficit Disorder (ADD) – a severe difficulty in focusing and maintaining attention; often leads to learning and behavior problems at home, school, and work; also called Attention Deficit Hyperactivity Disorder (ADHD). Autism (Autism Society of America Home Page) Autism is a complex developmental disability that typically appears during the first three years of life. The result of neurological disorder that affects the functioning of the brain, autism and its associated behaviors have been estimatedRead MoreEssay on Warfare and its Psychological Impact4896 Words   |  20 Pagesthe fourth edition of the Diagnostic and Statistical Manual of Mental Disorders, a mental disorder is a clinically significant behavioral or psychological syndrome or pattern thats associated with current distress (a painful symptom) or disability (impairment in one or more important areas of functioning) or with a significantly greater risk of suffering, death, pain, disability, or an important loss of freedom. This syndrome or pattern mustnt be merely an expected, culturally sanctioned responseRead MoreEssay Grief and Bereavement in The Catcher in the Rye2485 Words   |  10 Pageswill not expose -or admit to. If there are 785 instances of profanity in the book, I contend there are well over a hundred scenes where Holden used the word depressed.   DAmbrosio presents this same thought saying, It should be obvious by now that I dont see The Catcher in the Rye as a coming of age story . . . adolescence isnt the source of Holdens outsized feelings(37).     Ã‚  Ã‚  Ã‚  Ã‚   The experience of being in a state of grief is not limited by age but by experience.   The symptoms

Sunday, May 10, 2020

Civility And Lateral Violence Within Nursing - 1068 Words

Civility and Lateral Violence in Nursing Civility in the work place, or the lack thereof, has been identified as a growing problem within many professions in today’s society. Often referred to as lateral violence, this occurrence is no exception in the nursing profession. It is also known as ‘horizontal violence’ or ‘workplace bullying (Coursey, Rodriguez, Dieckmann, Austin, 2013). In this evidenced-based paper, information will be provided in an effort to identify causes of lateral violence in the workplace and how to encourage civility. Lateral violence is defined as acts that occur between colleagues wherein, bullying is recognized as actions or doings enacted by one in a higher level of authority and the occurrences happen over time (Dellasega, 2009). The acts can be inconspicuous or obvious acts of verbal or non-verbal aggression. Relational aggression is one type of bullying demonstrated by psychological abuse. Some behavior indicators that characterize this type of aggression include gossiping, withholding important or pertinent information, shunning, or knowingly keep one in isolation. These behaviors can also extend beyond the walls of the workplace and can occur in face to face situation, an office area, or in cyberspace (Dellasega, 2009). Civility in the workplace is a mirror of the behavior exhibited in society as a whole. Civility is defined as behavior wherein the respect that is shown toward another person, makes that person feel valued, a beneficiary ofShow MoreRelatedThe Effects Of Lateral Violence On The Workplace1159 Words   |  5 PagesCivility in the work place, or the lack thereof, has been identified as a growing problem within many professions in today’s society. Often referred to as lateral violence, this occurrence is no exception in the nursing profession. It is also known as ‘horizontal violence’ or ‘workplace bullying (Coursey, Rodriguez, Dieckmann, Austin, 2013). In this evidenced-based paper, information will be provided in an effort to identify causes of lateral violence in the workplace and how to encourage civilityRead MoreThe Importance Of Incivility In Nursing1066 Words   |  5 Pages Nurse-to-nurse lateral violence or incivility profoundly raises occupational stress with physical, psychological, and organizational consequence(Embree, White, Bruner, 2013). I will discuss issues of incivility, importance to nursing, a scenario, creating a healthful environment, my specialty track, and my conclusion. Issue of Incivility Clay defined Incivility as low-intensity deviant behavior with ambiguous intent to harm the target in violation of workplace norms for mutual respect (2013)Read MoreThe Effect Of Incivility On Nursing Turnover And Patient Care1640 Words   |  7 PagesThe Effect of Incivility on Nursing Turnover and Patient Care Incivility is an umbrella term used to describe any type of negative behavior directed towards another individual that may impact the way that they behave and/or feel. While incidences of incivility may be visible in most professional careers, it’s significance in nursing has prompted a provisional statement from the American Nurses Association. â€Å"The nurse creates an ethical environment and culture of civility and kindness. Disregard forRead MoreIncivility Of Organizations : Who Is The Blame?1775 Words   |  8 Pagestranslates to poor customer service. Related to nurses and nursing students, it also may negatively influence patient outcomes (Harris 16). In an industry known for compassion and caring, it is troubling that incivility is so pronounced. When nurses and qualified nurse instructors are in short supply, it is important that any uncivil behavior is addressed and remedied, or there is a potential risk of personnel loss. Students that enter into nursing schools already face rigorous workloads, financial pressuresRead MoreBullying And Incivility ( B I )2524 Words   |  11 Pagesenforced. I have observed our leaders bully and did not speak up, so this may be one of the reasons why we as an organization have not been able to halt these behaviors and change the culture within the organization. Problem Bullying has been a longstanding culture in Nursing. When I started my nursing career in 1998, some seasoned Nurses were in a huddle and they said, nurses eat their young.† I replied, What does that mean? They all said in concert, â€Å"you will see.† Well unfortunatelyRead MoreFundamentals of Hrm263904 Words   |  1056 PagesBenefit? 302 Sick Leave 302 Short-Term Disability Plans 303 Long-Term Disability Plans 303 WORKPLACE ISSUES: OSHA’s Top Ten Violations 324 Training for Employees, Supervisors and Managers 325 Contemporary Health and Safety Issues 325 Workplace Violence 325 Indoor Air Quality 326 The Smoke-Free Environment 327 WORKPLACE ISSUES: Faith in the Slaughterhouse 327 Repetitive Stress Injuries 328 Stress 328 Common Causes of Stress 329 DID YOU KNOW?: Employees Wasting Time at Work 330 Symptoms of StressRead MoreStephen P. Robbins Timothy A. Judge (2011) Organizational Behaviour 15th Edition New Jersey: Prentice Hall393164 Words   |  1573 PagesPrinter/Binder: Courier/Kendallville Cover Printer: Courier/Kendalville Text Font: 10.5/12 ITC New Baskerville Std Credits and acknowledgments borrowed from other sources and reproduced, with permission, in this textbook appear on the appropriate page within text. Copyright  © 2013, 2011, 2009, 2007, 2005 by Pearson Education, Inc., publishing as Prentice Hall. All rights reserved. Manufactured in the United States of America. This publication is protected by Copyright, and permission should be obtainedRead MoreProject Mgmt296381 Words   |  1186 Pagespursue a career in project management? Project managers must deal with all these concerns to be effective. All of these issues and problems represent linkages to an integrative project management view. The chapter content of the text has been placed within an overall framework that integrates these topics in a holistic manner. Cases and snapshots are included from the experiences of practicing managers. The future for project managers appears to be promising. Careers will be determined by success in

Wednesday, May 6, 2020

Civil V Criminal Law Free Essays

English law is made up primarily of Civil and Criminal Law. Civil Law is concerned with the the Laws of Tort and Contract. Civil law can be defined as that area of law which is concerned with private disputes that occur between individuals or between individuals and organisations and where a proceedings in court is initiated by the aforementioned. We will write a custom essay sample on Civil V Criminal Law or any similar topic only for you Order Now In contrast, criminal law seeks to punish those that has done wrongs against the community. For example, a person who decides to take the life of someone else commits murder. The community by way of its government has a duty to protect itself from being murdered. The result is Criminal Law which is enforceable by the State and initiated by the Police. Therefore criminal law is said to protect the community and punishes those that breaks the law with a fine, imprisonment or community sentences. Whereas, civil law seeks to compensate party who has suffered wrong. Civil law covers many areas of everyday daily life, most notable are domestic relations law like divorces and child custody law, probate like wills and estates, employment like agency and working hours laws, and personal injury law. Under pining those laws are Tort and Contract Law. A high level definition of tort law is that it deals with wrongs or injuries inflicted on one party by another and usually the parties involved are unknown to each other until something occurs which results in the tort action. Contracts on the other hand deals with the roles, relationships and obligations of parties that are engaged in a formal agreement. Under civil law an example of tort is acts of carelessness, or failure to act which result in injury or loss to another person. An example is a driver who fails to drive properly and as a result of that failure injures a pedestrian. This incident can give rise to negligence which is the failure to take reasonable care to avoid injury or loss to another person. However in order to prove a negligent claim, it must be proved that there existed a duty of care on the driver to not cause harm to others. The test of this duty of care is that the court will need to determine that a reasonable person would expect that a certain result might follow from an action. Therefore, by not driving properly the driver mounts the pavement and hits the pedestrian, if the result is foreseeable for a reasonable person, then liability may be imposed for the action. In comparison, contract law is an agreement between two persons where one binds himself, with respect to the other, to give something or to render some service. As such, a contract is said to be binding with obligations, and if not met, may lead to an action in civil court. For example a plumber hired to undertake the repair of a leaky facet has entered into a contract to repair the leaking facet in exchange for payment, if he fails to repair the facet within the terms of the agreement, there might not be any obligation to pay him as the terms of the contract has not met. To conclude, civil law covers several area of laws and is primarily concerned with private individuals or companies. The use of the term civil law as a blanket term to cover tort and contract is not confusing as the actions undertaken by the individuals will be indicative of the area of the law that is applicable. The principles are distinguishable, tort usually involves persons who have not entered into a contract or a formal relationship whereas contracts are legally binding agreements established by two or more persons. Where there might be a blurring of the distinctions is where there arises a case of tort while undertaking a contract. Such as an accident in the workplace where there exist a contract of employment. Bibliographies â€Å"Civil Law† Directgov http://www. direct. gov. uk/en/CrimeJusticeAndTheLaw/Thejudicialsystem/DG_4003097 â€Å"Criminal Law† Directgov http://www. direct. gov. uk/en/CrimeJusticeAndTheLaw/Thejudicialsystem/DG_4003097 â€Å"Tort† Stanford University http://plato. stanford. edu/entries/tort-theories/ How to cite Civil V Criminal Law, Papers

Thursday, April 30, 2020

Romeo And Juliet With Friar Essays - English-language Films

Romeo And Juliet With Friar Throughout Romeo and Juliet the tragedy written by William Shakespeare there are examples of tragic heroes. There are seven things needed to be a tragic hero, the character has to be of high rank, originally good, in a conflict, flawed, realize his error too late, become isolated, and produce a caratharis. The Friar in this play expresses and shows all of these traits, and therefore can be considered a tragic hero. The Friar is of high rank because he is a priest and a priest at that time period was considered to be the highest of all. He is also highly ranked because he was intellectual and could communicate well with others. The Friar is originally good because he tries to marry Romeo and Juliet to unite the two households but it does not work out. He also is originally good because at first he does not think they should rush into things, but he thinks of uniting the households and goes along with the wedding. Here he shows his good intentions in changing his mind about marrying Romeo and Juliet when he says, "O, she knew well Thy love did read by rote, that could not spell. But come, young waverer, come go with me. Inn one respect I'll thy assistant be; For this alliance may so be happy prove To turn you households' rancor to pure love."(II iv 88-93). The Friar is in a conflict by involving himself in the whole marriage of Romeo and Juliet. He has to lie to everyone, which is also more trouble for him if he gets caught. He also is involved by not telling anyone about the love between Romeo and Juliet before his good intentions turned into a violent ending. He is also in a conflict because he does not tell the Prince of this and if the Prince finds out the punishment could be death. Being contradictory to his own words reveals the Friar's flaws, by first saying that he would not marry Romeo and Juliet and then doing it to unite the families. He is also impatient in marrying them too early. He also should have taken his own advice when he says, "Revolts from true birth, stumbling on abuse. Virtue itself turns vice, being misapplied And vice sometimes by action dignified."(II iii 20-23). He realizes his error too late because after the deaths of Romeo and Juliet, he realizes that he never should have married them in the first place and it was wrong to do it without the consent of the parents. The Friar is isolated from the rest of the people of Verona because he must keep the secret of the marriage otherwise he could be punished severely. He must not speak of this to anyone except Romeo who is banished, the Nurse who was no longer trusted by Juliet so she was not in there with them anymore and Juliet was unconscious in her family vault. The Friar shows caratharis by making the audience feel bad for him when he first tries to do something good and marries Romeo and Juliet. He also makes the reader feel bad for him because the reader hopes at the end when the Prince of Verona is giving out punishments that he does not give a punishment to the Friar because of his well-meaning acts throughout the play. The Prince helps show the Friar's pain by saying "For never was there a story of more woe than this of Juliet and her Romeo."(V iii 309-310). Therefore the Friar has shown all of the seven traits needed to be a tragic hero and will be considered the tragic hero of this play. Others who could be considered tragic heroes are Romeo, Benvolio and Juliet.